These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 17974973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W, Rook SL, Jiang ZY, Takahara N, Aiello LP.
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA, Merlino G.
    Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M, Shen X, Huang L, Carpenter WM, Lin CS, Silverman S, Regezi J, Kramer RH.
    Int J Oncol; 2004 Oct 07; 25(4):831-40. PubMed ID: 15375530
    [Abstract] [Full Text] [Related]

  • 7. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H, Washington S, Verderame MF, Manni A.
    Breast Cancer Res Treat; 2008 Nov 07; 112(2):255-61. PubMed ID: 18097746
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J.
    Invest Ophthalmol Vis Sci; 2008 Feb 07; 49(2):497-504. PubMed ID: 18234991
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation.
    Nakamura T, Kanda S, Yamamoto K, Kohno T, Maeda K, Matsuyama T, Kanetake H.
    Oncogene; 2001 Nov 15; 20(52):7610-23. PubMed ID: 11753639
    [Abstract] [Full Text] [Related]

  • 15. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H, Holt RU, Rø TB, Fagerli UM, Hjorth-Hansen H, Baykov V, Christensen JG, Waage A, Sundan A, Børset M.
    Clin Cancer Res; 2004 Oct 01; 10(19):6686-94. PubMed ID: 15475459
    [Abstract] [Full Text] [Related]

  • 16. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis.
    Day RM, Cioce V, Breckenridge D, Castagnino P, Bottaro DP.
    Oncogene; 1999 Jun 03; 18(22):3399-406. PubMed ID: 10362361
    [Abstract] [Full Text] [Related]

  • 17. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
    Matsuda K, Idezawa T, You XJ, Kothari NH, Fan H, Korc M.
    Cancer Res; 2002 Oct 01; 62(19):5611-7. PubMed ID: 12359775
    [Abstract] [Full Text] [Related]

  • 18. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K, Hashimoto T, Kitamura N, Tanaka T.
    Mol Cancer Res; 2009 Jul 01; 7(7):1179-88. PubMed ID: 19567783
    [Abstract] [Full Text] [Related]

  • 19. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH.
    Toxicol Appl Pharmacol; 2008 Jan 15; 226(2):178-91. PubMed ID: 17961621
    [Abstract] [Full Text] [Related]

  • 20. Critical role of extracellular signal-regulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition.
    Osada S, Saji S, Osada K.
    Cancer; 2001 Mar 15; 91(6):1156-65. PubMed ID: 11267961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.